Join us for an insightful Panel Discussion at the CRSF 07th Masterclass in Lung Cancer, moderated by Dr. Akhil Kapoor. This session focuses on the latest strategies and treatment options for ALK-positive Non-Small Cell Lung Cancer (NSCLC).

Session Highlights:

Treatment Overview: Explore the current standard of care for ALK+ NSCLC, including first-line therapies and their efficacy.
Expert Panel: A group of leading oncologists and specialists will discuss various treatment modalities such as ALK inhibitors, combination therapies, and emerging options.
Clinical Insights: Gain valuable perspectives on decision-making, patient management, and the integration of new treatments into clinical practice.
Moderator: Dr. Akhil Kapoor
Panelists: Esteemed experts providing a comprehensive evaluation of first-line treatment options for ALK+ NSCLC.

This panel discussion is designed to enhance understanding and provide practical guidance for oncologists and healthcare professionals involved in the treatment of ALK+ NSCLC.

Supported by the Institute of Pulmonology Medical Research & Development and SUNACT, with Sunrise Oncology Centre as the hospital partner, this masterclass offers essential insights into advancing lung cancer treatment.

#LungCancer #OncologyMasterclass #ALKPositiveNSCLC #FirstLineTreatment #DrAkhilKapoor #CancerResearch #CRSF #CancerTreatment #MedicalInnovation #SunriseOncologyCentre #LungCancerAwareness #CRSFLungCancerMasterclass #PanelDiscussion #TargetedTherapy

свернуть